Company Filing History:
Years Active: 2012
Title: Subra Sankar: Innovating Nucleic Acid Sequencing
Introduction: Subra Sankar, located in Hayward, CA, has made significant contributions in the field of genetic analysis with his innovative approaches to sequencing nucleic acids. He holds one patent that showcases his expertise in developing systems and devices that enhance the efficiency and accuracy of genetic sequencing.
Latest Patents: Subra Sankar's notable patent, titled "Systems and Devices for Sequence by Synthesis Analysis," pertains to the sequencing of nucleic acids. This groundbreaking invention focuses on short DNA sequences derived from clonally amplified single-molecule arrays, providing a streamlined process for analyzing genetic material.
Career Highlights: Subra Sankar is currently employed at Illumina Corporation, a leader in genomics and biotechnology. His work is instrumental in advancing the capabilities of DNA sequencing technologies, paving the way for more precise genetic research and applications.
Collaborations: Throughout his career, Subra has collaborated with esteemed colleagues such as Saibal Banerjee and Colin Lloyd Barnes. These partnerships have fostered an environment of innovation, further enhancing the development of cutting-edge sequencing technologies.
Conclusion: Subra Sankar's contributions to the field of nucleic acid sequencing demonstrate the key role inventors play in scientific advancements. Through his patent and collaborative efforts, he continues to drive innovations that are essential for future discoveries in genetics and biotechnology.